While many genetic markers have been identified as being associated with cardiovascular disease (CVD), it is unknown whether genetic screening improves a doctors ability to predict cardiac risk for events such as heart attack, stroke, coronary revascularization, or cardiovascular death.
Read MoreExagen Diagnostics Inc announced an exclusive sales and marketing agreement with EndoChoice to promote its diagnostic services to gastroenterologists throughout the US.
Read MoreMediware Information Systems, a provider of ClosedLoop clinical systems for blood and medication management, announced that Oregon Health Sciences University (OHSU) Hospital has implemented the company’s BloodSafe system.
Read MoreSequenom Inc announced the launch of the SensiGene Fetal(XY) (Fetal Sex Determination) test by Sequenom’s CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM).
Read MoreDiagnoCure Inc will be splitting its business structure into two different parts: administrative headquarters in Quebec City, holder of the PCA3, GCC and Shc patents, and (2) DiagnoCure Oncology Laboratories (DOL), DiagnoCure’s US wholly-owned sales, marketing and service laboratory operations.
Read More